04/09/2024
3:10 PM | Relmada Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
3:15 PM | Relmada Therapeutics (Filer)
| Form DEFA14A | |
03/06/2024
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:53 AM | Deep Track Capital, LP (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
6:49 AM | Relmada Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
4:13 PM | Relmada Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/31/2024
5:28 PM | Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/31/2024
5:28 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
5:29 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:30 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
7:11 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
4:27 PM | Ence Chuck (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:27 PM | Fedeli Fabiana (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:27 PM | GLASSPOOL JOHN (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:28 PM | Kelly Paul Edward (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:28 PM | Relmada Therapeutics (Issuer)
Shenouda Maged (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:28 PM | Relmada Therapeutics (Issuer)
TRAVERSA SERGIO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:26 PM | CASAMENTO CHARLES J (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
8:00 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
4:18 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:53 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
3:47 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
8:23 AM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
Relmada Therapeutics (Subject)
| Form SC 13G/A | |
06/21/2023
4:00 PM | Relmada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/25/2023
3:28 PM | Relmada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
8:00 AM | O'Gorman Cedric (Reporting)
Relmada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
